Market Overview:
The global healthcare arrhythmia monitoring devices market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of arrhythmias, technological advancements in cardiac monitoring devices, and rising demand for home-based cardiac monitoring devices. Based on type, the global healthcare arrhythmia monitoring devices market is segmented into resting ECG devices, ECG stress test devices, Holter monitors, implantable cardiac monitors (ICMs), and others. The resting ECG device segment is expected to account for the largest share of the global healthcare arrhythmia monitoring devices market in 2018. This can be attributed to its growing use in primary care settings for diagnosis of various heart conditions. Based on application, the global healthcare arrhythmia monitoringdevices market is segmented into hospitals, clinics,, and others (including research institutes and home-care settings).
Product Definition:
A Healthcare Arrhythmia Monitoring Device is a piece of medical equipment that is used to monitor the heart rhythm of a patient. This device can help to detect and diagnose any abnormalities in the heart rhythm, which can then be treated accordingly.
Resting ECG Devices:
Rising prevalence of cardiovascular diseases and increasing demand for early diagnosis are the major factors driving the growth of this market. According to WHO, in 2015, 17.7 million people died from CVDs which accounts for 31% deaths globally.
ECG Stress Test Devices:
Stress test devices are used to evaluate the response of the heart to physical or mental stress. It is also known as cardiac response monitor (CRM) testing. The tests are performed by placing a finger on either side of the chest, and observing for any abnormal heartbeats that may indicate an arrhythmia.
Application Insights:
Based on application, the market is segmented into hospitals, clinics and other healthcare facilities, and others. The hospitals segment dominated the overall industry in terms of revenue in 2017. This high share is attributable to a large patient base with atrial fibrillation that necessitates long-term monitoring for preventing complications related to AF. Furthermore, an increase in the geriatric population across various regions coupled with a rise in lifestyle disorders such as obesity increases the demand for arrhythmia monitoring devices among hospitals and clinics.
The others segment includes patients¢â‚¬â„¢ homes as well as corporate or private offices of healthcare providers who do not have their own EKG lab or hospital beds but require medical device testing services. These service providers are looking for cost-effective solutions that can help them meet increasing demand while maintaining profitability margins during tough economic times which may further drive growth over next few years.
Regional Analysis:
North America dominated the global market in 2017. High adoption of healthcare facilities, favorable government initiatives, and high awareness regarding arrhythmia management are some of the major factors responsible for its large share. For instance, according to a study published in JAMA Cardiology in 2015 found that more than half (57%) of individuals with heart disease reported having a conversation about their cardiac health with a doctor or nurse during the past year. In addition, 45% discussed their heart health with friends or family members during this same period.
Asia Pacific is expected to grow at an exponential rate over the forecast period owing to increasing geriatric population and prevalence of hypertension which increases one's risk for developing an arrhythmia condition.
Growth Factors:
- Increasing prevalence of arrhythmia: The global prevalence of arrhythmia is expected to increase significantly in the next few years, owing to the increasing aging population and rising incidence of cardiovascular diseases. This will create significant demand for arrhythmia monitoring devices, thereby driving the growth of the healthcare arrhythmia monitoring devices market.
- Technological advancements: The development of novel and advanced technologies has led to the introduction of innovative and sophisticated arrhythmia monitoring devices in the market. This is likely to boost demand for these devices in the coming years, propelling market growth.
- Growing awareness about heart health: There is a growing awareness among people about heart health and its importance in leading a healthy life. This is resulting in an increased demand for preventive cardiac care services, including arrhythmia monitoring, thereby fueling market growth.
Scope Of The Report
Report Attributes
Report Details
Report Title
Healthcare Arrhythmia Monitoring Devices Market Research Report
By Type
Resting ECG Devices, ECG Stress Test Devices, Holter Monitors, Implantable Cardiac Monitors, Others,
By Application
Hospitals, Clinics, Others,
By Companies
GE Healthcare, Medtronic, Abbott Laboratories (St. Jude Medical), Nihon Kohden, Philips Healthcare, Hill-Rom (Welch Allyn), Biotronik, OSI Systems (Spacelabs Healthcare), NUUBO Smart Solutions Technologies, Fukuda Denshi, BioTelemetry
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Healthcare Arrhythmia Monitoring Devices Market Report Segments:
The global Healthcare Arrhythmia Monitoring Devices market is segmented on the basis of:
Types
Resting ECG Devices, ECG Stress Test Devices, Holter Monitors, Implantable Cardiac Monitors, Others,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GE Healthcare
- Medtronic
- Abbott Laboratories (St. Jude Medical)
- Nihon Kohden
- Philips Healthcare
- Hill-Rom (Welch Allyn)
- Biotronik
- OSI Systems (Spacelabs Healthcare)
- NUUBO Smart Solutions Technologies
- Fukuda Denshi
- BioTelemetry
Highlights of The Healthcare Arrhythmia Monitoring Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Resting ECG Devices
- ECG Stress Test Devices
- Holter Monitors
- Implantable Cardiac Monitors
- Others
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Healthcare Arrhythmia Monitoring Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Healthcare Arrhythmia Monitoring Devices (HAMDs) are medical devices that are used to monitor the heart rhythm of patients. Healthcare AMDs can be used to detect and diagnose atrial fibrillation, ventricular tachycardia, and other arrhythmias.
Some of the major players in the healthcare arrhythmia monitoring devices market are GE Healthcare, Medtronic, Abbott Laboratories (St. Jude Medical), Nihon Kohden, Philips Healthcare, Hill-Rom (Welch Allyn), Biotronik, OSI Systems (Spacelabs Healthcare), NUUBO Smart Solutions Technologies, Fukuda Denshi, BioTelemetry.
The healthcare arrhythmia monitoring devices market is expected to grow at a compound annual growth rate of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Healthcare Arrhythmia Monitoring Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Healthcare Arrhythmia Monitoring Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Healthcare Arrhythmia Monitoring Devices Market - Supply Chain
4.5. Global Healthcare Arrhythmia Monitoring Devices Market Forecast
4.5.1. Healthcare Arrhythmia Monitoring Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Healthcare Arrhythmia Monitoring Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Healthcare Arrhythmia Monitoring Devices Market Absolute $ Opportunity
5. Global Healthcare Arrhythmia Monitoring Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Healthcare Arrhythmia Monitoring Devices Market Size and Volume Forecast by Type
5.3.1. Resting ECG Devices
5.3.2. ECG Stress Test Devices
5.3.3. Holter Monitors
5.3.4. Implantable Cardiac Monitors
5.3.5. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Healthcare Arrhythmia Monitoring Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Healthcare Arrhythmia Monitoring Devices Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Healthcare Arrhythmia Monitoring Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Healthcare Arrhythmia Monitoring Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Healthcare Arrhythmia Monitoring Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Healthcare Arrhythmia Monitoring Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Healthcare Arrhythmia Monitoring Devices Demand Share Forecast, 2019-2026
9. North America Healthcare Arrhythmia Monitoring Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Healthcare Arrhythmia Monitoring Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Healthcare Arrhythmia Monitoring Devices Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Healthcare Arrhythmia Monitoring Devices Market Size and Volume Forecast by Type
9.7.1. Resting ECG Devices
9.7.2. ECG Stress Test Devices
9.7.3. Holter Monitors
9.7.4. Implantable Cardiac Monitors
9.7.5. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Healthcare Arrhythmia Monitoring Devices Demand Share Forecast, 2019-2026
10. Latin America Healthcare Arrhythmia Monitoring Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Healthcare Arrhythmia Monitoring Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Healthcare Arrhythmia Monitoring Devices Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Healthcare Arrhythmia Monitoring Devices Market Size and Volume Forecast by Type
10.7.1. Resting ECG Devices
10.7.2. ECG Stress Test Devices
10.7.3. Holter Monitors
10.7.4. Implantable Cardiac Monitors
10.7.5. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Healthcare Arrhythmia Monitoring Devices Demand Share Forecast, 2019-2026
11. Europe Healthcare Arrhythmia Monitoring Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Healthcare Arrhythmia Monitoring Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Healthcare Arrhythmia Monitoring Devices Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Healthcare Arrhythmia Monitoring Devices Market Size and Volume Forecast by Type
11.7.1. Resting ECG Devices
11.7.2. ECG Stress Test Devices
11.7.3. Holter Monitors
11.7.4. Implantable Cardiac Monitors
11.7.5. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Healthcare Arrhythmia Monitoring Devices Demand Share, 2019-2026
12. Asia Pacific Healthcare Arrhythmia Monitoring Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Healthcare Arrhythmia Monitoring Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Healthcare Arrhythmia Monitoring Devices Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Healthcare Arrhythmia Monitoring Devices Market Size and Volume Forecast by Type
12.7.1. Resting ECG Devices
12.7.2. ECG Stress Test Devices
12.7.3. Holter Monitors
12.7.4. Implantable Cardiac Monitors
12.7.5. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Healthcare Arrhythmia Monitoring Devices Demand Share, 2019-2026
13. Middle East & Africa Healthcare Arrhythmia Monitoring Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Healthcare Arrhythmia Monitoring Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Healthcare Arrhythmia Monitoring Devices Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Healthcare Arrhythmia Monitoring Devices Market Size and Volume Forecast by Type
13.7.1. Resting ECG Devices
13.7.2. ECG Stress Test Devices
13.7.3. Holter Monitors
13.7.4. Implantable Cardiac Monitors
13.7.5. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Healthcare Arrhythmia Monitoring Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Healthcare Arrhythmia Monitoring Devices Market: Market Share Analysis
14.2. Healthcare Arrhythmia Monitoring Devices Distributors and Customers
14.3. Healthcare Arrhythmia Monitoring Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. GE Healthcare
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Medtronic
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Abbott Laboratories (St. Jude Medical)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Nihon Kohden
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Philips Healthcare
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Hill-Rom (Welch Allyn)
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Biotronik
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. OSI Systems (Spacelabs Healthcare)
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. NUUBO Smart Solutions Technologies
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Fukuda Denshi
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. BioTelemetry
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
